ATORVASTATIN
10 mg / 20 mg / 40 mg / 80 mg

Reg. No. 42/7.5/0552, 0553, 0554, 0555
Pack: 30’s
 

Reg. No. 37/7.1.3/0613; 34/7.1.3/0433, 0434
Carvedilol 6.25 mg / 12.5 mg / 25 mg
Pack: 30’s
 

Reg. No. 32/7.1.4/0660
Nifedipine 20 mg SR
Pack: 60’s
 

Reg. No. 41/7.3.1/0674, 0675
Perindopril Erbumine 4 mg / 8 mg
Pack: 30 Tablets
 

Reg. No. 41/7.1.3/0824, 0825
Losartan Potassium 50 mg / 100 mg
Pack: 30's
Angiotensin Receptor Blocker (ARB) anti-hypertensive agent and the first of this class of blood pressure medicine to be genericised. The size of the local ARB market is R252 million while the size of the ACE-Inhibitor market is R317 million, making the combined market R569 million. We anticipate Cipla-Losartan to be one of our top 10 products within 6 months.
 

Reg. No. 40/7.5/0397, 0398; 38/7.5/0370, 0371
Simvastatin 10 mg/20 mg/40 mg/80 mg
Pack: 30's
 

Reg. No. 35/7.1.3/0033, 0034, 0285
Enalapril Maleate 5 mg / 10 mg / 20 mg
Pack: 30’s
 

41/8.2/0766
Clopidogrel hydrogen sulphate equivalent to 75mg clopidogrel


Pack: 30 Tablets
A new generic clopidogrel. Clopidogrel has very strong data supporting risk reduction of cardiovascular events. Since Clopivas is more affordable, more patients will be able to afford clopidogrel for the full recommended treatment period
 

Reg. No. 36/7.1.3/0071; 35/7.1.3/0252, 0359
Lisinopril 5 mg / 10 mg / 20 mg
Pack: 30's